Condensed Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Operating activities:
Net loss	$ (1,155,493)	$ (1,054,806)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	0	1,418
Non-cash share-based compensation	270,258	219,901
Non-cash interest expense	106,630	69,400
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(16,991)	(12,731)
Accounts payable	(3,693)	(64,613)
Accrued expenses	60,577	5,182
Operating lease liability	(2,133)	(2,245)
Unearned revenue	(57,571)	(57,571)
Net cash used in operating activities	(798,416)	(896,065)
Financing activities:
Proceeds from promissory note	55,400	0
Proceeds from the sale of convertible notes	0	1,300,000
Proceeds from the exercise of stock warrants	241,911	240,625
Net cash provided by financing activities	297,311	1,540,625
Net (decrease) increase in cash and cash equivalents	(501,105)	644,560
Cash and cash equivalents at beginning of period	639,916	237,261
Cash and cash equivalents at end of period	138,811	881,821
Supplemental Disclosures of Non-Cash Operating and Financing Activities:
Conversion of promissory notes to common stock	0	55,000
Conversion of accrued interest to common stock	0	13,941
Establish right-of-use asset	81,890	59,822
Establish operating lease liability	81,890	65,415
Issuance of warrants in conjunction with issuance of convertible notes	0	348,443
Beneficial conversions feature on issuance of convertible notes	$ 0	$ 348,443